Cargando…
Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
The use of intrapleural therapy with tissue plasminogen activator and DNase improves outcomes in patients with complicated pleural space infections. However, little data exists for the use of combination intrapleural therapy after the initial dosing period of six doses. We sought to describe the saf...
Autores principales: | McClune, Jason R., Wilshire, Candice L., Gorden, Jed A., Louie, Brian E., Farviar, Alexander S., Stefanski, Michael J., Vallieres, Eric, Aye, Ralph W., Gilbert, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944060/ https://www.ncbi.nlm.nih.gov/pubmed/27445574 http://dx.doi.org/10.1155/2016/9796768 |
Ejemplares similares
-
Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial
por: Wilshire, Candice L., et al.
Publicado: (2023) -
Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
por: Bédat, Benoît, et al.
Publicado: (2019) -
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
por: Lau, Estee P.M., et al.
Publicado: (2022) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
por: Kanellakis, Nikolaos I, et al.
Publicado: (2019) -
Cumulative radiation dose incurred during the management of complex pleural space infection
por: Gilbert, Christopher R., et al.
Publicado: (2021)